Mattel Has Been Downgraded by analysts BioPharma Consumer Cyclicals Diversified Financial Macro Markets Software & ServicesApril 14, 2014 Mattel, Inc. (MAT) price target has been reduced from $40 to $33 a share. Sharing Twitter0 Facebook0 Google +0 Linkedinactive){li-icon[type=linkedin-bug][color=inverse] .background{fill Email this article Print this article Tags BMO, BMO Capital Markets, Capital Markets, MAT, Toy maker Mattel Inc.